Compounds > 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone

2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and vitamin k 3

2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone has been researched along with vitamin k 3 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C; Liu, YZ; Shia, KS; Tseng, HY1
Bhasin, D; Chettiar, SN; Etter, JP; Li, PK; Mok, M1
Danilenko, NV; Karpenko, AS; Khlebnikov, AI; Kirpotina, LN; Levandovskiy, IA; Quinn, MT; Schepetkin, IA; Shibinska, MO1

Other Studies

3 other study(ies) available for 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and vitamin k 3

ArticleYear
Synthesis and anticancer evaluation of vitamin K(3) analogues.
    Bioorganic & medicinal chemistry letters, 2002, Oct-07, Volume: 12, Issue:19

    Topics: Antineoplastic Agents; Genes, MDR; Humans; Indicators and Reagents; Tumor Cells, Cultured; Vitamin K 3

2002
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
    Bioorganic & medicinal chemistry, 2013, Aug-01, Volume: 21, Issue:15

    Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Models, Molecular; Naphthoquinones; Structure-Activity Relationship

2013
Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Antineoplastic Agents; cdc25 Phosphatases; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Humans; MAP Kinase Kinase 7; Models, Molecular; Molecular Docking Simulation; Naphthoquinones

2019